Three-way complex translocations in infant acute myeloid leukemia with t(7;12)(q36;p13): the incidence and correlation of a HLXB9 overexpression.

[1]  A. Borkhardt,et al.  Graft versus leukemia effect after haploidentical HSCT in a MLL‐negative infant AML with HLXB9/ETV6 rearrangement , 2008, Pediatric blood & cancer.

[2]  R. Pieters,et al.  High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9 , 2006, Genes, chromosomes & cancer.

[3]  S. Bohlander.  ETV6: a versatile player in leukemogenesis. , 2005, Seminars in cancer biology.

[4]  S. Scherer,et al.  Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia , 2003, Genes, chromosomes & cancer.

[5]  L. Oseth,et al.  Cytogenetic and molecular heterogeneity of 7q36/12p13 rearrangements in childhood AML , 2002, Leukemia.

[6]  M. K. Magnússon,et al.  Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene. , 2002, Blood.

[7]  B. Johansson,et al.  Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13). , 2001, Cancer research.

[8]  D. Weghuis,et al.  t(7;12)(q36;p13) and t(7;12)(q32;p13) – translocations involving ETV6 in children 18 months of age or younger with myeloid disorders , 2001, Leukemia.

[9]  S. Scherer,et al.  t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia , 2000, Genes, chromosomes & cancer.

[10]  P. Marynen,et al.  Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. , 1998, Blood.

[11]  L. Shaffer,et al.  Comprar ISCN 2009 - An International System for Human Cytogenetic Nomenclature | Marilyn L. Slovak | 9783805589857 | Karger AG , 2009 .